|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Strategies to obtain pattern fidelity in nanowire growth from large-area surfaces patterned using nanoimprint lithography显示文摘位置控制 nanowire 生长为依靠轻排放或轻吸收的基于 nanowire 的 optoelectronic 部件是重要的。为收获应用程序的太阳能, nanowires 的稠密的数组被需要;然而,到获得稠密的 nanowire 数组的一个主要障碍是种子粒子排水量并且在 nanowire 生长以前在退火的舞台期间联合。这里,我们探索三不同策略改进 nanoimprint 平版印刷术为 nanowire 生长定义的大区域的催化剂粒子数组的模式保藏。首先,我们看到在 nanoimprint 平版印刷术以前对待生长底层的热改进模式保藏。第二,我们探索由在由修改生长过程退火以前在地方修理种子粒子改进模式保藏的可能性。并且第三,我们证明一个罪恶 x 生长面具罐头充分阻止种子粒子排水量。我们显示出这些策略怎么允许我们极大地与对太阳能电池应用合适的尺寸改进成年 InP nanowire 数组的模式忠实,在取样的区域上的最终完成的 100% 模式保藏。这些策略的通用性质通过 GaAs 和差距 nanowires 的合成被支持。 | Gaute Otnes Magnus Heurlin Mariusz Graczyk Jesper Wallentin Daniel Jacobsson Alexander Berg Ivan Maximov Magnus T. Borgstrom | 2016 | Nano Research2016，9，10： | 6 |
| 2 | 急性冠状动脉综合征发生1个月后的生长分化因子15水平与主要出血风险增加相关显示文摘用双重抗血小板治疗的急性冠状动脉综合征(acutecoronarysyndromes,ACS)患者在初次就诊测量的生长分化因子15(growthdifferentiationfactor-15,GDF-15)与大出血相关。 | Lindholm D Hagstrm E James SK Becker RC Cannon CP Himmelmann A Katus HA Maurer G López-Sendón JL Steg PG Storey RF Siegbahn A Wallentin L 刘莉 叶鹏 | 2017 | 中华高血压杂志2017，25，5： | 5 |
| 3 | In Situ Etching for Total Control Over Axial and Radial Nanowire Growth显示文摘We report a method using in situ etching to decouple the axial from the radial nanowire growth pathway,independent of other growth parameters.Thereby a wide range of growth parameters can be explored to improve the nanowire properties without concern of tapering or excess structural defects formed during radial growth.We demonstrate the method using etching by HCl during InP nanowire growth.The improved crystal quality of etched nanowires is indicated by strongly enhanced photoluminescence as compared to reference nanowires obtained without etching. | Magnus T.Borgström Jesper Wallentin Johanna Trägårdh Peter Ramvall Martin Ek LReine Wallenberg Lars Samuelson Knut Deppert | 2010 | Nano Research2010，3，4： | 4 |
| 4 | Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective, Randomized PLATO Trial显示文摘 | P. Gabriel Steg Robert A. Harrington H?kan Emanuelsson Hugo A. Katus Kenneth W. Mahaffey Bernhard Meier Robert F. Storey Daniel M. Wojdyla Basil S. Lewis Gerald Maurer Lars Wallentin Stefan K. James | 2013 | Circulation2013，，10： | 2 |
| 5 | Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy显示文摘 | Ziad Hijazi Jonas Oldgren Ulrika Andersson Stuart J. Connolly Michael D. Ezekowitz Stefan H. Hohnloser Paul A. Reilly Dragos Vinereanu Agneta Siegbahn Salim Yusuf Lars Wallentin | 2012 | Circulation2012，，13： | 2 |
| 6 | Relationship between intedeukin 6 and mortality in patients with unstable coronary artery diease:effects of an early invasive or noninvasive strategy显示文摘 | Lindmark E Diderholm E Wallentin L | 2001 | JAMA2001，286，17： | 1 |
| 7 | Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes : a genetic substudy of the Plato trial 显示文摘 | Ticagrelor versus clopidogrel in paN Engl J Med 2009 361(11): Wallentin L James S Storey RF | 2010 | Lancet2010，376，9749： | 1 |
| 8 | Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘 | Wallentin L Becker RC Budaj A | 2009 | N EnglJ Med2009，361，： | 1 |
| 9 | Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial 显示文摘 | Wallentin L Hijazi Z Andersson U | 2014 | Circulation2014，130，21： | 1 |
| 10 | Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes显示文摘 | Robert F. Storey Dominick J. Angiolillo Shankar B. Patil Bhaloo Desai Rosemary Ecob Steen Husted Hakan Emanuelsson Christopher P. Cannon Richard C. Becker Lars Wallentin | 2010 | Journal of the American College of Cardiology2010，，： | 1 |
| 11 | Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘 | Wallentin L Becker RC Budaj A | 2009 | N Engl J Med2009，361，11： | 1 |
| 12 | Persistant inhibition of platelet function during long- term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease显示文摘 | Wallentin L | 1991 | Eur Heart J1991，12，： | 1 |
| 13 | Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease, effects of an early invasive or noninvasive strategy显示文摘 | Lindmark E Diderholm E Wallentin L | 2001 | JAMA2001，286，： | 1 |
| 14 | Anticoagulants in heart disease: current status and perspectives 显示文摘 | de Caterina R Husted S Wallentin L | 2007 | Eur Heart J2007，28，： | 1 |
| 15 | Ticagrelor versus Clopidogrel inpatients with acute coronary syndromes J显示文摘 | Wallentin L Becker RC Budaj A | 2009 | N Engl J Med2009，361，： | 1 |
| 16 | Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study显示文摘 | Lind L Wallentin L Kempf T | 2009 | Eur Heart J2009，30，： | 1 |
| 17 | Ticagrelor versus clopidogrel in patients with acute coronary syndromes显示文摘 | WALLENTIN L BECKER RC BUDAJ A | 2009 | N Engl J Med2009，361，11： | 1 |
| 18 | Effect of CYP2C19 and ABCBI single nucleotide polymorphisms on outcomes of treat- ment with ticagrelor versus clopidogrel for acute coronary syndromes : a genetic substudy of the Plato trial显示文摘 | WALLENTIN L JAMES S STOREY R F | 2010 | Lancet2010，376，9749： | 1 |
| 19 | Ticagrelor versus clopidogrel inpatients with acute coronary syndromes显示文摘 | Wallentin L Becker R C Budaj A | 2009 | New England Journal of Medicine2009，361，11： | 1 |
| 20 | Tieagrelor versus clopidogrel in patients with acutecoronary syndromes 显示文摘 | Wallentin L Beeker RC Budaj A | 2009 | N Engl J Med2009，361，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员